<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155922</url>
  </required_header>
  <id_info>
    <org_study_id>9261700953</org_study_id>
    <nct_id>NCT00155922</nct_id>
  </id_info>
  <brief_title>The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients</brief_title>
  <official_title>The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients, Special Relevance to Atherosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The investigators hypothesize that macrophages play a crucial role in the pathogenesis of&#xD;
      atherosclerosis in patients with type 2 diabetes mellitus (T2DM).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular events are the leading cause of death in developed countries worldwide,&#xD;
      including Taiwan. Type 2 diabetes mellitus (T2DM), previously considered merely as one of the&#xD;
      risk factors, has been recently unanimously accepted to be coronary artery&#xD;
      disease-equivalent. How T2DM may lead to accelerated atherosclerosis remains obscure.&#xD;
&#xD;
      Hyperglycemia with or without hyperinsulinemia may lead to higher oxidative stress and&#xD;
      generalized inflammation. The oxidative stress and inflammation may play a significant role&#xD;
      in the pathogenesis in diabetic complications, including micro- and macro-vascular&#xD;
      complications. Macrophages together with T-lymphocytes are the earliest cell-types found in&#xD;
      fatty-streaks, the earliest atherosclerotic lesions. Macrophages are also well known cellular&#xD;
      mediators of oxidative stress and inflammation. Therefore, it is plausible to hypothesize&#xD;
      that macrophages play a crucial role in the pathogenesis of atherosclerosis in patients with&#xD;
      T2DM. In addition, the other cell types of the peripheral white blood cells (WBC), such as&#xD;
      neutrophils, have been shown to be intimately related to acute coronary syndrome. Therefore,&#xD;
      the study on the biology of peripheral WBCs may tell us something about the pathophysiology&#xD;
      of diabetic macro-vascular complications.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
        1. Normal control: fasting plasma glucose (FPG) less than 126 mg/dl.&#xD;
&#xD;
        2. T2DM: FPG &gt;＝126 mg/dl.&#xD;
&#xD;
             -  Group 1 (good glycemic control): hemoglobin A1c (HbA1c) &lt;＝ 7% in the past 6 months&#xD;
&#xD;
             -  Group 2 (poor glycemic control): HbA1c &gt;＝ 8% in the past 6 months&#xD;
&#xD;
        3. Blood sample will be collected at baseline and after aggressive control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2003</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>100</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Atherosclerosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Normal control: fasting plasma glucose (FPG) less than 126 mg/dl.&#xD;
&#xD;
          -  T2DM: FPG &gt;＝126 mg/dl.&#xD;
&#xD;
               -  Group 1 (good glycemic control): HbA1c&lt;＝7% in the past 6 months&#xD;
&#xD;
               -  Group 2 (poor glycemic control): HbA1c&gt;＝8% in the past 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute systemic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei-Shiung Yang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei-Shiung Yang, MD, PhD</last_name>
    <phone>886-2-2312-3456</phone>
    <phone_ext>7258</phone_ext>
    <email>wsyang@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10012</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei-Shiung Yang, MD, PhD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>7258</phone_ext>
      <email>wsyang@ha.mc.ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>December 13, 2006</last_update_submitted>
  <last_update_submitted_qc>December 13, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2006</last_update_posted>
  <keyword>Diabetes mellitus</keyword>
  <keyword>Monocyte</keyword>
  <keyword>Gene expression</keyword>
  <keyword>Monocyte gene expression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

